Characteristics of clinical trials of new oncology drugs approved in China (English)
- New search for: Yang, Jing
- New search for: Yang, Ji
- New search for: Hu, Yuan‐Jia
- New search for: Yang, Jing
- New search for: Yang, Ji
- New search for: Hu, Yuan‐Jia
In:
Cancer
;
130
, 5
;
671-682
;
2024
- Article (Journal) / Electronic Resource
-
Title:Characteristics of clinical trials of new oncology drugs approved in China
-
Contributors:
-
Published in:Cancer ; 130, 5 ; 671-682
-
Publisher:
-
Publication date:2024-03-01
-
Size:12 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 130, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 649
-
Issue Information| 2024
- 656
-
Updated American Cancer Society lung cancer screening guidelinesNierengarten, Mary Beth et al. | 2024
- 657
-
Continuous expansion of telehealth in cancer careNierengarten, Mary Beth et al. | 2024
- 658
-
Helping patients with cancer to understand secondary findings on genetic testsNierengarten, Mary Beth et al. | 2024
- 659
-
Lessons from ADAURA: Can we improve on a positive trial?West, Howard (Jack) / Pennell, Nathan A. et al. | 2024
- 665
-
Critical insights into the evolving drug‐approval process in ChinaNikanjam, Mina / Kurzrock, Razelle et al. | 2024
- 668
-
An invisible population: Late‐stage cancer diagnosis for people with intellectual or developmental disabilityMcMahon, Martin / McCallion, Phillip / McCarron, Mary et al. | 2024
- 671
-
Characteristics of clinical trials of new oncology drugs approved in ChinaYang, Jing / Yang, Ji / Hu, Yuan‐Jia et al. | 2024
- 683
-
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancervan Veggel, Bianca A. M. H. / van der Wekken, Anthonie J. / Paats, Marthe S. / Hendriks, Lizza E. L. / Hashemi, Sayed M. S. / Daletzakis, Antonios / van den Broek, Daan / Bosch, Linda J. W. / Monkhorst, Kim / Smit, Egbert F. et al. | 2024
- 692
-
Genomic ancestry in kidney cancer: Correlations with clinical and molecular featuresKotecha, Ritesh R. / Knezevic, Andrea / Arora, Kanika / Bandlamudi, Chaitanya / Kuo, Fengshen / Carlo, Maria I. / Fitzgerald, Kelly N. / Feldman, Darren R. / Shah, Neil J. / Reznik, Ed et al. | 2024
- 702
-
A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)Ho, Alan L. / Foster, Nathan R. / Deraje Vasudeva, Shyamprasad / Katabi, Nora / Antonescu, Cristina R. / Frenette, Gary P. / Pfister, David G. / Erlichman, Charles / Schwartz, Gary K. et al. | 2024
- 713
-
A surrogate molecular approach for the detection of Philadelphia chromosome–like B‐acute lymphoblastic leukemiaGupta, Dikshat Gopal / Varma, Neelam / Abdulkadir, Sarki Abba / Sreedharanunni, Sreejesh / Sachdeva, Man Updesh Singh / Naseem, Shano / Bose, Parveen / Binota, Jogeshwar / Malhotra, Pankaj / Khadwal, Alka et al. | 2024
- 727
-
A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokineticsPullarkat, Vinod / Chen, Lisa S. / Palmer, Joycelynne / Zhang, Jianying / Synold, Timothy W. / Buettner, Ralf / Truong Nguyen, Le Xuan / Marcucci, Guido / Tsai, Ni‐Chun / Wang, Yan et al. | 2024
- 740
-
Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population‐based cross‐sectional studyMahar, Alyson L. / Biggs, Kelly / Hansford, Rebecca L. / Derksen, Shelley / Griffiths, Rebecca / Enns, Jennifer E. / Dawe, David E. / Hallet, Julie / Kristjanson, Mark / Decker, Kathleen et al. | 2024
- 750
-
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017Rosenberg, Shoshana M. / McCue, Shaylene / He, Jun / Lafky, Jacqueline M. / Carey, Lisa A. / Galanis, Evanthia / Leonard, John P. / Meyerhardt, Jeffrey / Ng, Kimmie / Schwartz, Gary K. et al. | 2024
- 770
-
Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction modelChoi, Eunji / Luo, Sophia J. / Ding, Victoria Y. / Wu, Julie T. / Kumar, Ashok V. / Wampfler, Jason / Tammemägi, Martin C. / Wilkens, Lynne R. / Aredo, Jacqueline V. / Backhus, Leah M. et al. | 2024
- 781
-
Does breast cancer modify the long‐term relationship between lifestyle behaviors and mortality? A prospective analysis of breast cancer survivors and population‐based controlsGali, Kathleen / Orban, Ester / Ozga, Ann‐Kathrin / Möhl, Annika / Behrens, Sabine / Holleczek, Bernd / Becher, Heiko / Obi, Nadia / Chang‐Claude, Jenny et al. | 2024
- 792
-
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532Evageliou, Nicholas / Renfro, Lindsay A. / Geller, James / Perlman, Elizabeth / Kalapurakal, John / Paulino, Arnold / Dix, David / Eklund, Meryle J. / Murphy, Andrew J. / Romao, Rodrigo L. P. et al. | 2024
- 803
-
Health care utilization by long‐term survivors of blood or marrow transplantation—A Bone Marrow Transplant Survivor Study reportOliver, Marian M. / Meng, Qingrui / Hageman, Lindsey / Landier, Wendy / Balas, Nora / Ross, Elizabeth / Francisco, Liton / Bosworth, Alysia / Te, Hok Sreng / Wong, F. Lennie et al. | 2024
- 816
-
Employment and workdays lost among spouses of cancer survivors: Intersection with gender across cancer treatment statusLitzelman, Kristin / Han, Xuesong / Zhao, Jingxuan / Zheng, Zhiyuan / Yabroff, K. Robin et al. | 2024